-Reuters
Moderna Shares Linger At 2-Month Lows: What’s Next For The COVID-19 Vaccine Company
Moderna Inc (NASDAQ: MRNA) stock is trading at its lowest level since late July. This once high-flying stock that notched up stratospheric gains from its COVID-19 program has lost altitude.